Bone in CKD, a fascinating evolving topic

Cannata-Andía, J.; Carrillo-López, N.; Ferreira, A.

Affiliations

¹Bone and Mineral Research Unit, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Universidad de Oviedo, Retic REDinREN-ISCIII, Avda. Roma, sn., 33011 Oviedo, Spain

²Nephrology Department, Centro Hospitalar e Universitário de Lisboa Central, Nova Medical School, Nova University, Lisbon, Portugal

Links

DOI: 10.1007/s00223-021-00821-8

PubMed: 33822254

WoS: 000637454600001

History

Received: 2021-01-25

Accepted: 2021-01-30

Online: 2021-04-06

Cited Works (12)

Year	Entry
2021	Mazzaferro S, Bagordo D, Martini ND, Pasquali M, Rotondi S, Tartaglione L, Stenvinkel P; ERA-EDTA CKD-MBD working group. Inflammation, oxidative stress, and bone in chronic kidney disease in the osteoimmunology era. Calcif Tiss Int. April 2021;108(4):452-460.
2021	Jørgensen HS, David K, Salam S, Evenepoel P; European Renal Osteodystrophy (EUROD) workgroup, an initiative of the CKD-MBD working group of the ERA-EDTA. Traditional and non-traditional risk factors for osteoporosis in CKD. Calcif Tiss Int. April 2021;108(4):496-511.
2009	KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD–MBD). Kidney Int. August 2009;76(suppl 113):S1-S130.
2021	Ferreira AC, Cohen-Solal M, D’Haese PC, Ferreira A; European Renal Osteodystrophy (EUROD), an initiative of the CKD-MBD working group of the ERA-EDTA. The role of bone biopsy in the management of CKD-MBD. Calcif Tiss Int. April 2021;108(4):528-538.
2015	West SL, Lok CE, Langsetmo L, Cheung AM, Szabo E, Pearce D, Fusaro M, Wald R, Weinstein J, Jamal SA. Bone mineral density predicts fractures in chronic kidney disease. J Bone Miner Res. May 2015;30(5):913-919.
2021	Bover J, Ureña-Torres P, Cozzolino M, Rodríguez-García M, Gómez-Alonso C. The non-invasive diagnosis of bone disorders in CKD. Calcif Tiss Int. April 2021;108(4):512-527.
2021	Komaba H, Ketteler M, Cunningham J, Fukagawa M. Old and new drugs for the management of bone disorders in CKD. Calcif Tiss Int. April 2021;108(4):486-495.
2021	Leal DV, Ferreira A, Watson EL, Wilund KR, Viana JL. Muscle-bone crosstalk in chronic kidney disease: the potential modulatory effects of exercise. Calcif Tiss Int. April 2021;108(4):461-475.
2021	Torregrosa J-V, Ferreira AC, Cucchiari D, Ferreira A. Bone mineral disease after kidney transplantation. Calcif Tiss Int. April 2021;108(4):551-560.
2006	Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. June 1, 2006;69(11):1945-1953.
2021	Fusaro M, Cianciolo G, Evenepoel P, Schurgers L, Plebani M. Vitamin K in CKD bone disorders. Calcif Tiss Int. April 2021;108(4):476-485.
2021	Santos F, Díaz-Anadón L, Ordóñez FA, Haffner D. Bone disease in CKD in children. Calcif Tiss Int. April 2021;108(4):423-438.